pharm extra credit 1-10

pharm extra credit 1-10 - Jake Sebastian #1 Pharm 1000...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
Jake Sebastian #1 Pharm 1000 Sept. 7, 2010 This article is about how robberies at pharmacies have been on the rise for the past couple of years. This is mainly due to the increased demand for prescription grade painkillers such as hydrocodone and oxycontin. According to this article, the prescription painkillers are one of the most common illegal drug problems, second only to marijuana. The article also mentions how robberies don’t just come from random individuals who have their eyes on the prize from the second they pull up to the parking lot; robberies have also come from within the store itself with workers being caught stealing up to thousands of dollars worth of painkillers. Over the past three years, there has been a steady incline in occurrences but it’s hard to have a tally for the entire nation since not all burglaries are reported as a drug thefts. Some big corporations like CVS and Walgreens have stepped up to fight off any intentions of their stores being hit by robberies by adding new surveillance technology and installing safes for prescription pain killers. Other pharmacies, particularly individually owned pharmacies have been purposely labeling fake bottles of painkillers and would surrender those bottles in an armed robbery attempt. http://www.foxnews.com/us/2010/09/07/robbers-striking-pharmacies-abusing- prescription-drugs-popular/ Pharm 1001 #2 Jake Sebastian This article is on how the FDA has approved an oral drug for the condition multiple sclerosis, a disease that affects hundreds and thousands of people. The disease is an autoimmune disease that affects the brain and the spinal cord, which make up the Central Nervous System. Nerve damage is the result of this progressive disease, which means that over time, the condition gets worse. The causes of the onset of this disease are unknown, but it is thought to be a virus or genetic defect. The drug is named Gilenya and is made by Novartis International AG. The drug reduces symptoms displayed by MS such as physical disabilities. According to the article, the oral form of administering this drug may appeal to many people as the alternative from the current therapy used to treat this disease, which is in the form of needles. The potential side effects of the drug are risk of infection and toxicity of the eyes, liver, lungs and the heart. The article suggests that patients talk to their doctors before switching to the oral form if they are currently using the injection treatment, which has no serious side effects. Within the next couple of weeks, the drug should be ready to
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
be filled for prescriptions. http://voices.washingtonpost.com/checkup/2010/09/fda_approves_first_oral_drug_t.html
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 5

pharm extra credit 1-10 - Jake Sebastian #1 Pharm 1000...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online